Home > PJ (Current issue) > Meetings and Conferences | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 268 No 7198 p694-696
18 May 2002

This article
Reprint
Photocopy

Meetings and Conferences

European Society of Clinical Pharmacy summary


Metabolic problems with HAART

Metabolic abnormalities occurred in 75 per cent of patients on highly active anti-retroviral therapy (HAART) in a study in Slovenia. The most common effects were hyperlipidaemia and insulin resistance. Raised cholesterol levels occurred in 21 per cent of patients and raised triglycerides in 49 per cent.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal